Plasma S100A8 and S100A9 Are Strong Prognostic Factors for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure

Figure 1

Baseline levels of plasma S100A8 and S100A9 in HBV-ACLF patients. (a) Comparison of plasma S100A8 (b) and S100A9 between HBV-ACLF patients, CHB patients, and HCs. (c) Comparison of plasma S100A8 (d) and S100A9 among different EASL-ACLF grade subgroups of patients (e) Comparison of plasma S100A8 and (f) S100A9 among different COSSH-ACLF grade subgroups of patients. (g) Comparison of S100A8 (h) and S100A9 mRNA levels between HBV-ACLF patients, CHB patients, and HCs. Horizontal lines and error bars represent media ±95% confidence interval (CI).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)